HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.

Abstract
Improving small interfering RNA (siRNA) efficacy in target cell populations remains a challenge to its clinical implementation. Here, we report a chemical modification, consisting of phosphorodithioate (PS2) and 2'-O-Methyl (2'-OMe) MePS2 on one nucleotide that significantly enhances potency and resistance to degradation for various siRNAs. We find enhanced potency stems from an unforeseen increase in siRNA loading to the RNA-induced silencing complex, likely due to the unique interaction mediated by 2'-OMe and PS2. We demonstrate the therapeutic utility of MePS2 siRNAs in chemoresistant ovarian cancer mouse models via targeting GRAM domain containing 1B (GRAMD1B), a protein involved in chemoresistance. GRAMD1B silencing is achieved in tumours following MePS2-modified siRNA treatment, leading to a synergistic anti-tumour effect in combination with paclitaxel. Given the previously limited success in enhancing siRNA potency with chemically modified siRNAs, our findings represent an important advance in siRNA design with the potential for application in numerous cancer types.
AuthorsSherry Y Wu, Xianbin Yang, Kshipra M Gharpure, Hiroto Hatakeyama, Martin Egli, Michael H McGuire, Archana S Nagaraja, Takahito M Miyake, Rajesha Rupaimoole, Chad V Pecot, Morgan Taylor, Sunila Pradeep, Malgorzata Sierant, Cristian Rodriguez-Aguayo, Hyun J Choi, Rebecca A Previs, Guillermo N Armaiz-Pena, Li Huang, Carlos Martinez, Tom Hassell, Cristina Ivan, Vasudha Sehgal, Richa Singhania, Hee-Dong Han, Chang Su, Ji Hoon Kim, Heather J Dalton, Chandra Kovvali, Khandan Keyomarsi, Nigel A J McMillan, Willem W Overwijk, Jinsong Liu, Ju-Seog Lee, Keith A Baggerly, Gabriel Lopez-Berestein, Prahlad T Ram, Barbara Nawrot, Anil K Sood
JournalNature communications (Nat Commun) Vol. 5 Pg. 3459 (Mar 12 2014) ISSN: 2041-1723 [Electronic] England
PMID24619206 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Phosphates
  • RNA, Small Interfering
  • RNA-Induced Silencing Complex
  • phosphorodithioic acid
Topics
  • Animals
  • Cell Line, Tumor
  • Female
  • Humans
  • Immunohistochemistry
  • Mice
  • Mice, Nude
  • Phosphates (chemistry)
  • RNA, Small Interfering (chemistry, therapeutic use)
  • RNA-Induced Silencing Complex (chemistry, metabolism)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: